Kopran Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Kopran Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 23% in 3 years, but profit fell: ₹1 less profit per ₹100 of extra sales. Lower than 85% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹132Over the last 3 years, every ₹100 of reported profit came with ₹132 of operating cash.
Higher than 62% of Healthcare companies in India.
Self-Funding Ratio
0.8×Over the last 3 years its own operating cash paid for 83% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 69% of Healthcare companies in India.
Cash Locked Ratio
₹35For every ₹100 of sales, ₹35 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹33 tied up three years earlier.
More money tied up than 71% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Less steady than 68% of Healthcare companies in India.
Growth Efficiency Ratio
−₹1Sales grew 23% in 3 years, but profit fell: ₹1 less profit per ₹100 of extra sales.
Lower than 85% of Healthcare companies in India.
Asset Productivity Ratio
+23% / +40%In 3 years sales changed by +23% while total assets changed by +40%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.5×Debt due within a year is covered 0.5 times by its yearly operating cash.
Lower than 71% of Healthcare companies in India.
Cash Cushion Ratio
−12%Debt, after subtracting cash, equals 12% of its market value (net debt).
Lower than 82% of Healthcare companies in India.
Tangible Assets Ratio
96%Of every ₹100 the company owns, ₹96 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 53% of Healthcare companies in India.
Tangible Net Worth Ratio
94%Of every ₹100 of net worth, ₹94 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 54% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Kopran Limited owes ₹0.42 for every ₹1 it owns. Net profit fell 33% in the year to Mar 2026, and shrank 2% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
47.6Investors pay ₹47.6 for every ₹1 of Kopran Limited's yearly profit, higher than 67% of Healthcare companies in India.
P/B ratio
2.24The share price is 2.24 times Kopran Limited's book value per share, lower than 80% of Healthcare companies in India.
Market cap
₹1,190 CrThe total market value of all of Kopran Limited's shares at today's price (share price × number of shares), smaller than 77% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹530 CrWhat Kopran Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹109.73Net worth divided by the number of shares. The share price of ₹246.30 is 2.2 times this, which is the P/B above.
Return on equity (ROE)
4.7%Kopran Limited earned 4.7% on its shareholders' money over the last year, lower than 83% of Healthcare companies in India.
Owes vs Owns
0.42×Kopran Limited owes ₹0.42 for every ₹1 it owns (low), higher than 63% of Healthcare companies in India.
Dividend yield
1.20%Kopran Limited pays 1.20% of its share price as dividends a year, higher than 84% of dividend-paying Healthcare companies in India.
Revenue growth
+8%Revenue rose 8% in the year to Mar 2026, and grew 7% a year on average over 3 years.
Profit growth
-33%Net profit fell 33% in the year to Mar 2026, and shrank 2% a year on average over 3 years.
Profit margin
3.8%Kopran Limited keeps ₹4 of every ₹100 of revenue as net profit.
Cash quality
2.6×Cash from Kopran Limited's business was 2.6× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
6.9×Kopran Limited's operating profit covered its interest costs 6.9 times in the year to Mar 2026.
Cash vs debt
Net debtKopran Limited had ₹152 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Kopran Limited's P/E ratio?
Investors pay ₹47.6 for every ₹1 of Kopran Limited's yearly profit, higher than 67% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Kopran Limited: ₹1,190 Cr ÷ ₹530 Cr (31 Mar 2026) = 2.2.
What is Kopran Limited's return on equity?
Kopran Limited earned 4.7% on its shareholders' money over the last year, lower than 83% of Healthcare companies in India.
How much does Kopran Limited owe compared with what it owns?
Kopran Limited owes ₹0.42 for every ₹1 it owns (low), higher than 63% of Healthcare companies in India.
Does Kopran Limited pay a dividend?
Yes. Kopran Limited pays 1.20% of its share price as dividends a year, higher than 84% of dividend-paying Healthcare companies in India.
Is Kopran Limited's revenue growing?
Revenue rose 8% in the year to Mar 2026, and grew 7% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.